Evidence mapPaperPMID 39763517Full record

ArticlemedRxiv : the preprint server for health sciences2024

Age at Menarche and Coronary Artery Disease Risk: Divergent Associations with Different Sources of Variation.

Ambreen Sonawalla, Daniel I Chasman, Yee-Ming Chan

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Ambreen SonawallaDivision of Endocrinology, Department of Pediatrics, Boston Children's Hospital.ORCID 0000-0003-4342-5343
Daniel I ChasmanDepartments of Pediatrics (A.S., Y.M.C.) and Medicine (D.I.C.), Harvard Medical School.ORCID 0000-0003-3357-0862
Yee-Ming ChanDivision of Endocrinology, Department of Pediatrics, Boston Children's Hospital.ORCID 0000-0003-0554-8502

Funding

Women's Health Study: Continued Follow-upR01CA047988 · BRIGHAM AND WOMEN'S HOSPITAL · 1991 to 2005
$15.2M
TRIAL OF VITAMIN E, BETA-CAROTENE &ASPRIN IN WOMENR01HL043851 · BRIGHAM AND WOMEN'S HOSPITAL · 1991 to 2000
$1.6M
RESEARCH IN DEVELOPMENTAL ENDOCRINOLOGY AND METABOLISMT32DK007699 · CHILDREN'S HOSPITAL BOSTON · 1992 to 2025
$1.3M
Women's Health Study: Continued Follow-UpR01HL080467 · BRIGHAM AND WOMEN'S HOSPITAL · 2005 to 2005
$889k
NCI NIH HHS R01 CA047988NCI NIH HHS UM1 CA182913NHLBI NIH HHS R01 HL043851NHLBI NIH HHS R01 HL080467NHLBI NIH HHS RC1 HL099355NIDDK NIH HHS T32 DK007699
6 · The paper itself

Abstract

Background: In women, both earlier and later age at menarche (AAM) are associated with increased risk of coronary artery disease (CAD). This study sought to determine if the relationship of AAM with CAD and CAD risk factors differs for different underlying sources of variation in AAM - specifically, variation attributable to common genetic variants as represented by a polygenic score (PGS) vs. variation in AAM adjusted for the PGS. Methods: Primary analyses were conducted on data from 201,037 women in the UK Biobank and validation studies on data from 23,268 women in the Women's Genome Health Study (WGHS). For each individual, a PGS for AAM was calculated, then two variables were estimated from linear regression models: the genetically predicted AAM (the estimated AAM for each woman solely due to the effects of common genetic variants) and the PGS-adjusted AAM (estimated AAM for each woman solely due to factors other than the PGS). Logistic regression and linear splines were then used to study the relationships of these variables with CAD and CAD risk factors. Results: Genetically predicted AAM demonstrated a linear relationship with CAD and linear or roughly linear relationships with CAD risk factors. In contrast, PGS-adjusted AAM demonstrated a U-shaped relationship with CAD and with hemoglobin A1c, triglycerides, HDL-C, and waist-hip ratio. Validation studies using WGHS data produced similar results. Conclusions: These results suggest that later AAM itself does not cause increased risk of CAD; rather, upstream sources of variation other than common genetic variants can cause both later AAM and increased risk of CAD. Dysglycemia, dyslipidemia, and central adiposity are candidate mediators of the association of later AAM with increased risk of CAD.

Indexed as

polygenic scorepubertal timingUK Biobankwomen

Identifiers

PMID39763517
PMCPMC11702712

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.